tert-Butyl 5-(hydroxymethyl)-7-oxo-2,6-diazaspiro[3.4]octane-2-carboxylate

Catalog No.: 
ACPYUQ506
CAS No.: 
1357353-37-7
Molecular Formula: 
C12H20N2O4
Molecular Weight: 
256.30
tert-Butyl 5-(hydroxymethyl)-7-oxo-2,6-diazaspiro[3.4]octane-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$292.00InquiryInquiry
100mg98%$429.00InquiryInquiry
250mg98%$603.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 5-(hydroxymethyl)-7-oxo-2,6-diazaspiro[3.4]octane-2-carboxylate
IUPAC Nametert-butyl 5-(hydroxymethyl)-7-oxo-2,6-diazaspiro[3.4]octane-2-carboxylate
MDL No.MFCD22209414
Molecular FormulaC12H20N2O4
Molecular Weight256.30
SMILESO=C(N1CC2(C(CO)NC(C2)=O)C1)OC(C)(C)C
InChI KeyMDXFMIQUBXXNON-UHFFFAOYSA-N
SynonymTert-Butyl 5-(Hydroxymethyl)-7-Oxo-2,6-Diazaspiro[3.4]Octane-2-Carboxylate(WX100919);Tert-Butyl 5-(Hydroxymethyl)-7-Oxo-2,6-Diazaspiro[3.4]Octane-2-Carboxylate;2,6-Diazaspiro[3.4]octane-2-carboxylic acid, 5-(hydroxymethyl)-7-oxo-, 1,1-dimethylethyl ester
CAS No.1357353-37-7

Synthetic Route by SureRoute

1. ACPYUQ506 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVJER206 route compound structure diagram
    ACVJER2061357351-87-1In Stock
  2. Then
  3. ACPYUQ506 route product structure diagram
    ACPYUQ5061357353-37-7
Inquiry

2. ACPYUQ506 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPYUQ506 route product structure diagram
    ACPYUQ5061357353-37-7
Inquiry

3. ACPYUQ506 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPYUQ506 route product structure diagram
    ACPYUQ5061357353-37-7
Inquiry

Comments (0)